As November 2025 unfolds, U.S. healthcare policy debates are intensifying. Key issues include escalating costs, equitable access, and regulatory oversight of artificial intelligence (AI). With Medicare spending projected to exceed $1 trillion annually by 2030, policymakers are working to curb administrative burdens while expanding coverage—particularly for mental health services amid a post-pandemic surge in demand.
The American Hospital Association (AHA) has urged the White House to streamline AI regulations. This would help avoid stifling innovation and driving up costs, with a call for aligned federal standards to support safe AI adoption in hospitals. Meanwhile, over 100 state-level AI bills introduced in 2025 focus on prohibiting biased algorithms in insurance decisions, reflecting bipartisan concerns about equity.
Technology, including virtual reality (VR), holds promise for addressing mental health crises, where 1 in 5 adults reports symptoms of anxiety or depression. VR offers immersive therapies that simulate exposure to phobias or PTSD triggers in controlled environments. This could potentially reduce reliance on medications. Yet, VR’s integration faces hurdles from the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA). CMS’s 2025 Physician Fee Schedule expands telehealth for mental health but stops short of broad VR reimbursement. The FDA’s focus on premarket reviews for AI-enabled VR devices creates delays. These barriers highlight a tension: Tech could democratize care, but without policy evolution, it risks remaining a luxury for the privately insured.
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
